Cargando…

Failures

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Butler, C. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	1889
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064426/ https://www.ncbi.nlm.nih.gov/pubmed/30749887

Ejemplares similares

Failures
por: Butler, C. R.
Publicado: (1889)

Primary Prevention of Heart Failure
por: Butler, Javed
Publicado: (2012)

Heart Failure
por: Giamouzis, Gregory, et al.
Publicado: (2011)

The Limitations of Symptom-based Heart Failure Management
por: Papadimitriou, Lampros, et al.
Publicado: (2019)

Maternal Heart Failure
por: Bright, Rachel A., et al.
Publicado: (2021)

Heart Failure 2012
por: Giamouzis, Gregory, et al.
Publicado: (2012)

Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
por: Talha, Khawaja M., et al.
Publicado: (2022)

Recognizing the Significance of Outpatient Worsening Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
por: Talha, Khawaja M., et al.
Publicado: (2022)

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
por: Talha, Khawaja M., et al.
Publicado: (2023)

Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event
por: Givertz, Michael M., et al.
Publicado: (2021)

Heart Failure in Pregnancy: A Problem Hiding in Plain Sight
por: Stergiopoulos, Kathleen, et al.
Publicado: (2019)

Prediction of worsening heart failure events and all‐cause mortality using an individualized risk stratification strategy
por: Zile, Michael R., et al.
Publicado: (2020)

The Cardioprotective Actions of Hydrogen Sulfide in Acute Myocardial Infarction and Heart Failure
por: Polhemus, David J., et al.
Publicado: (2014)

Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event
por: Butler, Javed, et al.
Publicado: (2020)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Frailty and heart failure: State‐of‐the‐art review
por: Talha, Khawaja M., et al.
Publicado: (2023)

Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
por: Giamouzis, Gregory, et al.
Publicado: (2016)

Predictors of heart failure development in type 2 diabetes: a practical approach
por: Verma, Subodh, et al.
Publicado: (2019)

Combined aquaretic and diuretic therapy in acute heart failure
por: Goyfman, Michael, et al.
Publicado: (2017)

Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic
por: HALL, MICHAEL E., et al.
Publicado: (2020)

Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
por: Packer, Milton, et al.
Publicado: (2023)

Failure to Rescue, Failure to Respond
por: Bromberger, Bianca, et al.
Publicado: (2023)

Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial
por: Butler, Javed, et al.
Publicado: (2022)

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
por: Packer, Milton, et al.
Publicado: (2021)

Management of Neonatal Respiratory Failure
por: Roberton, N. R. C.
Publicado: (1977)

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
por: Costes, Safia, et al.
Publicado: (2013)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
por: Fudim, Marat, et al.
Publicado: (2020)

Multi-energy spectral photon-counting computed tomography (MARS) for detection of arthroplasty implant failure
por: Lau, Lawrence Chun Man, et al.
Publicado: (2021)

Advanced cancer is also a heart failure syndrome: a hypothesis
por: Anker, Markus S., et al.
Publicado: (2021)

Clinical performance and quality measures for heart failure management in China: the China‐Heart Failure registry study
por: Zhang, Yuhui, et al.
Publicado: (2022)

ECG-AI: electrocardiographic artificial intelligence model for prediction of heart failure
por: Akbilgic, Oguz, et al.
Publicado: (2021)

Auricular Failure
por: Coombs, Carey F., et al.
Publicado: (1924)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Resistant hyponatraemia in a patient with follicular lymphoma and heart failure with reduced ejection fraction: a case report
por: Butler, Jennifer, et al.
Publicado: (2021)

Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
por: Schelbert, Erik B., et al.
Publicado: (2015)

Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials
por: Fiuzat, Mona, et al.
Publicado: (2022)

Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA‐REG OUTCOME trial
por: Verma, Subodh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m6sdigkkm3ig22hs1ubktjh7pt